【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
07.WHO Diagnostic Criteria for Type 2 Diabetes
08.Treatment Algorithm for Type 2 Diabetes by IDF
09.Incidence and Prevalence
10.Five Forces Analysis
11.Market Segmentation by Drug Class
11.1.1 DPP-4 Inhibitors
11.1.2 Biguanides
11.1.3 Insulin
11.1.4 GLP-1 Receptor Agonists
11.1.5 Thiazolidinediones
11.1.6 Insulin Secretagogues
11.1.7 SGLT-2 Inhibitors
11.1.8 Alpha-glucosidase Inhibitors
11.1.9 Others
12.Key Leading Countries
12.1 US
12.2 Japan
12.3 China
13.Geographical Segmentation
13.1 Type 2 Diabetes Therapeutics Market in Americas
13.1.1 Market Segmentation by Country 2014
13.1.2 Type 2 Diabetes Therapeutics Market in US
13.1.3 Type 2 Diabetes Therapeutics Market in Latin America
13.2 Type 2 Diabetes Therapeutics Market in APAC Region
13.2.1 Market Segmentation by Country 2014
13.2.2 Type 2 Diabetes Therapeutics Market in China
13.2.3 Type 2 Diabetes Therapeutics Market in Japan
13.2.4 Type 2 Diabetes Therapeutics Market in 5EU
13.3 Type 2 Diabetes Therapeutics Market in BRIC Countries
14.Buying Criteria
15.Market Growth Drivers
16.Drivers and their Impact
17.Market Challenges
18.Impact of Drivers and Challenges
19.Market Trends
20.Trends and their Impact
21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2013
21.2.1 AstraZeneca
21.2.2 Novartis
21.2.3 Novo Nordisk
21.3 Other Prominent Vendors
22.Key Vendor Analysis
22.1 AstraZeneca
22.1.1 Business Overview
22.1.2 Business Segmentation
22.1.3 Key Information
22.1.4 SWOT Analysis
23.2 Novartis
22.2.1 Business Overview
22.2.2 Business Segmentation
22.2.3 Key Information
22.2.4 SWOT Analysis
22.3 Novo Nordisk
22.3.1 Business Overview
22.3.2 Business Segmentation
22.3.3 Key Information
22.3.4 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Regulation of Blood Glucose Levels by Insulin and Glucagon
Exhibit 3: Major Complications Arising Because of Diabetes
Exhibit 4: Global Type 2 Diabetes Therapeutics Market 2014-2019 (US$ billion)
Exhibit 5: FDA Approved NMEs for Type 2 Diabetes 2011-2014
Exhibit 6: Conclusions of Time 2 Do More in Diabetes Survey
Exhibit 7: WHO Diagnostic Criteria for Type 2 Diabetes
Exhibit 8: Treatment Algorithm for Type 2 Diabetes by IDF
Exhibit 9: Advantages and Disadvantages of Using Metformin for Treatment of Type 2 Diabetes
Exhibit 10: Advantages and Disadvantages of Using Sulfonylureas and Alpha-glucosidase Inhibitors for Treatment of Type 2 Diabetes
Exhibit 11: Advantages and Disadvantages of Using Thiazolidinediones for Treatment of Type 2 Diabetes
Exhibit 12: Prevalence of Diabetes by IDF Region 2013
Exhibit 13: Prevalence of Diabetes 2013
Exhibit 14: Comparative Prevalence of Diabetes by IDF Region 2013 and 2035 (20-79 years)
Exhibit 15: Segmentation of Global Type 2 Diabetes Therapeutics Market by Drug Class
Exhibit 16: Segmentation of Global Type 2 Diabetes Therapeutics Market by Drug Class 2014
Exhibit 17: Insulin Secretagogues by Drug Class
Exhibit 18: Segmentation of Global Type 2 Diabetes Therapeutics Market by Geography 2014
Exhibit 19: Segmentation of Global Type 2 Diabetes Therapeutics Market by Geography 2019
Exhibit 20: Segmentation of Global Type 2 Diabetes Therapeutics Market by Geography 2014-2019 (US$ billion)
Exhibit 21: YoY Growth Rate of Global Type 2 Diabetes Therapeutics Market Segments by Geography 2014-2019
Exhibit 22: Segmentation of Global Type 2 Diabetes Therapeutics Market by Country/Region 2014
Exhibit 23: Type 2 Diabetes Therapeutics Market in Americas 2014-2019 (US$ billion)
Exhibit 24: Segmentation of Type 2 Diabetes Therapeutics Market in Americas by Country 2014
Exhibit 25: Type 2 Diabetes Therapeutics Market in US 2014-2019 (US$ billion)
Exhibit 26: Type 2 Diabetes Therapeutics Market in Latin America 2014-2019 (US$ billion)
Exhibit 27: Segmentation of Type 2 Diabetes Therapeutics Market in Latin America by Country 2014
Exhibit 28: Segmentation of Type 2 Diabetes Therapeutics Market in Latin America by Country 2019
Exhibit 29: Type 2 Diabetes Therapeutics Market in Mexico 2014-2019 (US$ billion)
Exhibit 30: Segmentation of Type 2 Diabetes Therapeutics Market in Latin America by Country 2014-2019 (US$ billion)
Exhibit 31: Type 2 Diabetes Therapeutics Market in Brazil 2014-2019 (US$ billion)
Exhibit 32: Type 2 Diabetes Therapeutics Market in APAC Region 2014-2019 (US$ billion)
Exhibit 33: Segmentation of Type 2 Diabetes Therapeutics Market in APAC Region by Country 2014
Exhibit 34: Type 2 Diabetes Therapeutics Market in China 2014-2019 (US$ billion)
Exhibit 35: Type 2 Diabetes Therapeutics Market in Japan 2014-2019 (US$ billion)
Exhibit 36: Type 2 Diabetes Therapeutics Market in 5EU 2014-2019 (US$ billion)
Exhibit 37: Segmentation of Type 2 Diabetes Therapeutics Market in BRIC Countries 2014
Exhibit 38: Blue Circle: Global Symbol for Diabetes
Exhibit 39: Prevalence of Diabetes by IDF Region 2013 and 2035
Exhibit 40: Prevalence of IGT by Age 2013 and 2035
Exhibit 41: Prevalence of Diabetes and Prevalence of Undiagnosed Diabetes by IDF Region 2013
Exhibit 42: Diabetes Rule of Halves
Exhibit 43: Revenue Share of Novo Nordisk’s Insulin Products 2013
Exhibit 44: Segmentation of NovoRapid/NovoLog by Geography 2013 (US$ million)
Exhibit 45: Segmentation of NovoRapid/NovoLog by Geography 2013
Exhibit 46: NovoRapid/NovoLog Market Size and Forecast 2013-2018 (US$ million)
Exhibit 47: Segmentation of Revenue from Novo Nordisk’s Insulin Products by Geography 2013
Exhibit 48: Segmentation of Revenue from Novo Nordisk’s Insulin Products by Geography 2013 (US$ million)
Exhibit 49: Segmentation of Victoza by Geography 2013 (US$ million)
Exhibit 50: Segmentation of Victoza by Geography 2013
Exhibit 51: Victoza Market Size and Forecast 2013-2018 (US$ million)
Exhibit 52: AstraZeneca plc: Business Segmentation by Revenue 2013
Exhibit 53: AstraZeneca plc: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 54: AstraZeneca plc: Sales by Geography 2013
Exhibit 55: Novartis AG: Business Segmentation
Exhibit 56: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 57: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 58: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 59: Business Segments of Novo Nordisk A/S 2013
Exhibit 60: Novo Nordisk A/S: Business Segmentation 2013
Exhibit 61: Novo Nordisk A/S: Revenue Comparison 2012 and 2013 (US$ million)
Exhibit 62: Novo Nordisk A/S: Sales by Geography 2013
【レポート販売概要】
■ タイトル:2型糖尿病治療薬の世界市場2015-2019■ 英文:Global Type 2 Diabetes Therapeutics Market 2015-2019
■ 発行日:2014年12月10日
■ 調査会社:Technavio
■ 商品コード:IRTNTR4813
■ 調査対象地域:グローバル
- ポイント・オブ・ケア検査の世界市場:グルコース監視キット、心血管代謝監視キット、感染症検査キット、凝集モニタリングキット、腫瘍マーカーThe global point-of-care (POC) diagnostics market is expected to reach USD 36.96 Billion by 2021 from USD 23.16 Billion in 2016, growing at a CAGR of 9.8% between 2016 and 2021. On the basis of products, the point-of-care diagnostics market is divided into 12 segments, namely, glucose monitoring kits, infectious diseases testing kits, cardiometabolic monitoring kits, coagulation monitoring kits, h …
- 卵管がん治療法の世界市場:標的療法、化学療法Global Fallopian Tube Cancer Therapeutics Market: About this market Fallopian tube cancer is a less common type of gynecologic cancer and accounts for approximately 1%-2% of all gynecologic cancer cases. Technavio’s fallopian tube cancer therapeutics market analysis considers sales from both targeted therapy and chemotherapy. Our analysis also considers the sales of fallopian tube cancer therapeut …
- 世界における前立腺がん検査製品のパイプライン動向2015Prostate Cancer - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Prostate Cancer - Pipeline Review, 2015" provides an overview of Prostate Cancer diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players …
- 微小電気機械システム(MEMS)の世界市場:タイプ別(センサー、およびアクチュエーター)、用途別(家庭用電化製品、自動車、産業、航空宇宙および防衛、ヘルスケア、およびテレコミュニケーション、その他)The micro-electromechanical systems (MEMS) technology includes very small, moving mechanical parts, and electrical components. This technology is used to fabricate sensors such as accelerometers, gyroscopes, digital compasses, inertial modules, pressure sensors, humidity sensors, and microphones. The MEMS technology holds the largest share in the overall sensor market across the globe. The impleme …
- スターター培養の世界市場予測:微生物別、用途別、組成別、フォーム別“The starter culture market is projected to grow at a CAGR of 5.3%; the key drivers include growth in the end-user industries such as dairy and dairy products, meat and sea food. Another key driver is the growing demand for dairy processing industries.”The global starter culture market size is estimated at USD 964 million in 2019 and projected to grow at a CAGR of 5.3% to reach USD 1,314 million b …
- Menactra (Meningococcal Vaccines):市場予測と分析(~2022)Menactra (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the meningococcal disease space is dominated by vaccines. Menactra (Meningococcal Gr …
- 世界の多関節ロボット市場:用途別、地域別分析About Articulated Robot An articulated robot is a robotic arm, which includes at least three rotary joints to perform precise movements in multiple planes. Articulated robots are widely used in the Manufacturing industry for various applications such as welding, sealing, assembling, material handling, picking, cutting, painting and spraying, and machine tending. These robots are also used in the A …
- 世界のクラウド基盤ITサービスマネジメント(ITSM)市場動向(2014~2018)TechNavio's analysts forecast the Global Cloud-based ITSM market to grow at a CAGR of 16.82 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for economical ITSM solutions. The Global Cloud-based ITSM market has also been witnessing the increasing use of personal devices in the workplace. However, the integration concerns with exi …
- モバイルプラットフォームにおけるポータブルアプリケーション(Mobile Applications and Widgets: Portable Applications on Mobile Platforms, Sixth Edition)Mobile Applications and Widgets: Portable Applications on Mobile Platforms, Sixth Edition provides a complete understanding of the mobile software marketplace. The reader will learn about mobile applications from the inception and evolution of applications on mobile platforms, to current market trends. The state of the current market is evaluated with reference to current market and data, financia …
- 2014年戦略提言:アメリカの呼吸器病診断検査市場About This ReportThis new 283-page report from Venture Planning Group presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public He …
- マルチベンダーATMソフトウェアの世界市場:コンポーネント別、機能別、エンドユーザー別Multivendor ATM software enables banks and financial institutions to take control of their ATM networks to reduce costs, increase functionality, and improve competitiveness. Many financial institutions have discovered the need to acquire innovative financial self-service equipment from different manufacturers. This generates the need to install a multivendor software solution to manage their ATM a …
- 世界の3Dバイオプリンティング市場:インクジェット・バイオプリンター、バルブベース細胞プリンター等About 3D Bioprinting 3D bioprinting is a process to produce tissues in a variety of formats from micro-scale tissues to standard multi-well tissues, where cell function and viability are preserved within the printed construct. A 3D bioprinter is a medical device used to regenerate human tissues, which are created by human cells. The 3D micro-engineered environments open new ¬channels for drug scre …
- 商業用冷蔵装置の世界市場分析:タイプ別(輸送冷凍装置、冷蔵庫・冷凍庫、ショーケース、飲料冷蔵、部品)、小売チャンネル別(超大型マーケット、スーパーマーケット、コンビニエンスストア、レストラン)、用途別(食品サービス、食品・飲料生産、食品・飲料流通、食品・飲料小売)、セグメント予測The global commercial refrigeration equipment market is expected to reach USD 52.52 billion by 2024, according to a new report by Grand View Research, Inc. Growing number of hypermarket and supermarket in developing regions has increased the demand of energy efficient equipment in the recent years. Rapid industrialization, rising disposable income and several other demographic shifts has led to si …
- 自動車用電動外部リアビュー(ORVM)ミラーの世界市場2019-2023About this market The increase in the production of passenger vehicles is one of the key factors expected to augment the automotive electrically adjustable ORVM market growth during the forecast period. The global production of passenger vehicles has increased serving the base for the growth of the market. Automotive electrically adjustable ORVMs are often being offered as standard fitments in the …
- 世界の三フッ化窒素市場2015The Global Nitrogen Trifluoride Industry Report 2015.pdf is a professional and in-depth study on the current state of the Nitrogen Trifluoride industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Nitrogen Trifluoride market analysis is provided for the international markets including development trends, …